Results 61 to 70 of about 9,015 (261)
Infection with respiratory syncytial virus (RSV) is one of the major causes globally of childhood respiratory morbidity and hospitalization. Palivizumab, a humanized monoclonal antibody, has been recommended for high risk infants to prevent severe RSV ...
Nusrat Homaira+3 more
doaj +1 more source
Background Palivizumab prophylaxis for the human respiratory syncytial virus (HRSV) has been reported to reduce the risk of hospital admissions related to HRSV in children with congenital heart disease (CHD). These children are at high risk of developing
Roseane Porfírio de Souza+3 more
doaj +1 more source
Passive Immunization in the Prevention and Treatment of Viral Infections
The development of new technologies for generating monoclonal antibodies has made it possible to extend the use of monoclonal antibodies for controlling viral infections. Here, we discuss the advances in antibody cloning techniques and the current use of passive immunization both as a preventative measure and treatment of viral infection.
Romila Moirangthem, Yotam Bar‐On
wiley +1 more source
Ann Haerskjold,1,2 Lonny Henriksen,2 Susanne Way,1 Mikkel Malham,3 Jesper Hallas,4 Lars Pedersen,5 Lone Graff Stensballe1 1The Child and Adolescent Clinic 4072, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; 2The Research Unit Women
Haerskjold A+6 more
doaj
Bronchiolitis: an update on management and prophylaxis. [PDF]
Bronchiolitis is an acute respiratory illness that is the leading cause of hospitalization in young children less than 2 years of age in the UK. Respiratory syncytial virus is the most common virus associated with bronchiolitis and has the highest ...
Bergroth E+38 more
core +1 more source
Disease Burden of RSV Infection in Adult Patients in Comparison to Influenza Virus Infection
ABSTRACT Respiratory Syncytial Virus (RSV) is well known for its impact on children, but its burden in adults remains underexplored, partly due to limited PCR testing before the COVID‐19 pandemic. In this study, the medical burden of RSV infections in adults was retrospectively investigated using 6‐year longitudinal data from a university hospital in ...
Georgii Trifonov+8 more
wiley +1 more source
Infektiologie Update 2018; 26. Jahrestagung der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG)
openaire +2 more sources
Abstract The use of matrix‐assisted laser desorption/ionization (MALDI) mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this review is the 12th update of the original article published in 1999 and brings coverage of the literature to the end of 2022.
David J. Harvey
wiley +1 more source
Caratteristiche farmacologiche e uso clinico del Palivizumab nel trattamento dell’infezione dal virus respiratorio sinciziale [PDF]
Uno dei principali patogeni del tratto inferiore respiratorio nei bambini sotto i 2 anni è il virus respiratorio sinciziale (RSV). Nel 2015 fu stimato dall’OMS che erano presenti circa 64 milioni di infezioni l’anno e 160mila morti in tutto il mondo ...
SASSETTI, FILIPPO
core
ABSTRACT Respiratory syncytial virus (RSV) remains a significant health concern, particularly for vulnerable populations. Despite preventive strategies, there remains a need for effective antiviral treatments. EDP‐323 is a first‐in‐class, potent oral selective non‐nucleoside inhibitor of the large protein (L polymerase) of RSV under investigation for ...
Kimberly Elmore+4 more
wiley +1 more source